EU Health Product Manufacturers Call for Guidance on Flexibility of Claims Wording

09 Feb 2012 --- Welcoming the European Commission’s decision to allow the food sector some flexibility when making claims, EHPM said that because of concerns that the average consumer will not understand some of the scientific terminology, claims should be accompanied by further explanatory details.

Feb 9 2012 --- Guidance on the acceptability of flexible wordings when communicating article 13.1 health claims to consumers will be valuable for both enforcement bodies and companies, the European Federation of Associations of Health Product Manufacturers (EHPM) has said.

Welcoming the European Commission’s decision to allow the food sector some flexibility when making claims, EHPM said that because of concerns that the average consumer will not understand some of the scientific terminology, claims should be accompanied by further explanatory details.

“We have concerns whether the average consumer will understand scientific terminology such as ‘Homocystein metabolism’, ‘normal neurotransmission’, ‘cell division and differentiation’ and ‘sulphur amino acid metabolism’,” said EHPM Chairman Peter van Doorn. “Consumers may not interpret correctly many of the wordings listed in the annex of the draft Regulation establishing a list of permitted health claims. Therefore, it is essential that wordings can be adapted to consumer language.”

The European trade association highlighted the dual and equal requirement in the Regulation for claims to be “based on generally accepted scientific evidence” and “well understood by the average consumer”.

EHPM said that based on these requirements companies should be permitted to mention some of the specific functions and definitions cited in the European Food Safety Authority’s (EFSA) opinions, stating that this would provide consumers with valuable advice.
 
“We believe that such clarifications would greatly assist consumer understanding,” said van Doorn. “For example, a message such as ‘Pantothenic acid contributes to normal mental performance’, which relates to EFSA’s definition of mental performance as standing for those aspects of brain and nerve functions which determine aspects like concentration, learning, memory and reasoning. We hope that the European Commission and Member States take into consideration this approach with regard to flexibility.”

Related Articles

Regulatory News

WHO: Over 170 Countries Make Commitments to Combat Malnutrition

20 Nov 2014 --- In a major step towards eradicating malnutrition worldwide, over 170 countries today made a number of concrete commitments and adopted a series of recommendations on policies and investments aimed at ensuring that all people have access to healthier and more sustainable diets.

Health & Nutrition News

CSPI Urges Dietary Guidelines Committee to Recommend Pregnant Women Avoid Caffeine, Coffee

20 Nov 2014 --- The federal government may be poised to give women who are or might become pregnant bad advice on how much caffeine is safe to consume during pregnancy, according to the Center for Science in the Public Interest. Draft advice from the government's Dietary Guidelines Advisory Committee indicates that pregnant women should be sure to limit their caffeine consumption to 200 milligrams per day.

Business News

Qualitas Health Meets Major Commercial Milestone with Almega PL

20 Nov 2014 --- Qualitas Health has announced the launch of the first consumer products based upon Almega PL, marking the company’s transition from research and development into successful commercialization of the company’s premium algal omega-3 oil.

Business News

Naturex Develops New Wellbeing Solutions for Seniors

18 Nov 2014 --- Naturex will showcase innovative natural food and beverage concepts that promote healthy ageing at the forthcoming Health Ingredients Europe 2014. The EU’s regulatory environment has caused many manufacturers to wonder if it’s still possible to innovate with strong health claims.

More Articles
URL : http://www.nutritioninsight.com:80/news/EU-Health-Product-Manufacturers-Call-for-Guidance-on-Flexibility-of-Claims-Wording.html